Anbio Biotechnology (NASDAQ:NNNN – Get Free Report)’s stock price rose 9.7% on Wednesday . The stock traded as high as $10.88 and last traded at $11.1320. 5,026 shares were traded during mid-day trading, a decline of 88% from the average daily volume of 43,634 shares. The stock had previously closed at $10.15.
Wall Street Analyst Weigh In
Separately, Weiss Ratings raised shares of Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, May 14th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company presently has an average rating of “Hold”.
Read Our Latest Research Report on NNNN
Anbio Biotechnology Stock Performance
About Anbio Biotechnology
Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.
Featured Stories
- Five stocks we like better than Anbio Biotechnology
- Meta’s AI Spending Problem Just Found a BlackRock Solution
- Broadcom’s $200 Billion Samsung Deal Shows How Costly the AI Memory Race Has Become
- 3 Refiners Benefiting From Oil Volatility and Tight Fuel Supply
- Carrier Earnings Could Send the Stock to a New All-Time High
Receive News & Ratings for Anbio Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anbio Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
